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Abstract
Background:  Japanese people have become increasingly interested in the expression and
enhancement of their individual autonomy in medical decisions made regarding medical treatment
at and toward the end of life. However, while many Western countries have implemented
legislation that deals with patient autonomy in the case of terminal illness, no such legislation exists
in Japan. The rationale for this research is based on the need to investigate patient's preferences
regarding treatment at the end of life in order to re-evaluate advance directives policy and practice.
Methods: We conducted a cross-sectional survey with 418 members of the general middle-aged
and senior adults (aged between 40 and 65) in Tokyo, Japan. Respondents were asked about their
attitudes toward advance directives, and preferences toward treatment options.
Results: Over 60% of respondents agreed that it is better to express their wishes regarding
advance directives (treatment preferences in writing, appointment of proxy for care decision
making, appointment of legal administrator of property, stating preferences regarding disposal of
one's property and funeral arrangements) but less than 10% of them had already done so. About
60% of respondents in this study preferred to indicate treatment preferences in broad rather than
concrete terms. Over 80% would like to decide treatment preferences in consultation with others
(22.2% with their proxy, 11.0% with the doctor, and 47.8% with both their proxy and the doctor).
Conclusion: This study revealed that many Japanese people indicate an interest in undertaking
advance directives. This study found that there is a range of preferences regarding how advance
directives are undertaken, thus it is important to recognize that any processes put into place should
allow flexibility in order to best respect patients' wishes and autonomy.
Background
In recent times, paternalistic decision making practices
and policies regarding life prolonging treatments have
widely been replaced by an emphasis on patient participa-
tion, respect for autonomy, and quality of life [1,2].
Research indicates that honoring the treatment prefer-
ences of terminally ill patients is critical for the provision
of high quality care at the end of life [3-6]. Advance care
planning including living wills and health care proxies
have become established to facilitate ways for patients to
specify the kind of medical treatment they desire in the
case of incapacitation. The designation and presence of a
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health care proxy is significantly associated with higher
patient satisfaction with comfort care plans[7]. Patients'
preferences are most often elicited through advance direc-
tives, and discussions regarding advance directives could
provide a framework for all treatment related decision-
making between medical professionals and patients in
addition to protecting patients in the event of decisional
incapacity[8].
In the United States, all 50 states and the District of
Columbia have passed legislation on advance direc-
tives[8]. In the United Kingdom, although the British
Medical Association cautiously approved the introduction
of advance directives in a statement in May 1992 [9], there
is still no legislation which deals with patient autonomy
in the case of terminal illness. This is similar to the situa-
tion in Japan where, although the Japan Medical Associa-
tion has officially declared that a patient's advance request
for death with dignity should be respected [10], advance
directives have no legal standing.
While the general public in Japan have become increas-
ingly interested in the expression and enhancement of
their individual autonomy in medical decisions made at
the end of life[11,12], one study has suggested there are
several possible barriers in the appropriate use of advance
directives[13]. In dealing with terminal patients, moreo-
ver, another study indicated that only half of Japanese
doctors gave priority to their patients' wishes for medical
care regardless of the patient's competency[14]. In the
light of this, there is a need to investigate patient's prefer-
ences regarding treatment at the end of life in order to re-
evaluate advance directives policy and practice.
When patients are deprived of decisional capacity due to
physical, mental and cognitive deterioration, family or
relatives are often asked to make judgments on behalf of
patients regarding treatment choices. A number of studies
have found, however, that both family members and care
professional show substantial inaccuracy in attempting to
predict patients' life-sustaining treatment preferences [15-
17]. In order to facilitate the proxy decision making proc-
ess, it is also useful to clarify what patients expect from
surrogate decision makers with regards to end-of-life deci-
sion-making.
More than 103,000 people have joined the Japan Society
for Dying with Dignity and have formulated a living will
[18]. Though the advance directives format used by the
Society gives no choice in terms of declaring wishes
regarding treatment options, several researchers in the
advanced directives field have pointed out that the desira-
bility of making an advance directive depends on its out-
come (e.g. life expectancy, chance of success) [19-21]. As
both qualitative[22] and quantitative data [23,24] sup-
port the importance of outcomes in patients' treatment
preferences, recent research indicates that advance direc-
tives should take into account patients' attitudes toward
the burden of treatment, the possible outcomes, and their
likelihood [25]. In order to examine the suitability of
processes for advance directives from the patient's per-
spective in Japan, we conducted a population-based sur-
vey to clarify the general public's preferences to treatment
with differing burden, outcomes and likelihood assuming
that this group might best represent patients' attitudes.
Methods
This study was a cross-sectional, stratified random sample
survey of the general middle-aged and senior adults (aged
between 40 and 65) in Tokyo, Japan. As people over 65
years old are epidemiologically more at risk of having
dementia, we excluded them from the sample not only
because it seemed harmful to ask them about dementia-
related matters, but also because there was a possibility
that their responses would be affected by any existing
symptoms. Participants were selected from the list of eli-
gible voters in A ward in Tokyo (which consists of 23
wards). This ward was selected as representative of Tokyo
because various social indices such as the proportion of
the elderly in the population, the average length of educa-
tion, and the population growth rate were consistent with
the Tokyo average[26]. A self-administered questionnaire
was sent via mail to 688 residents in March 2004. Of
these, 418 people responded (response rate 60.8 %; we
made two times requests for participation by letter). The
12 page questionnaire was developed in consultation
with 5 medical professionals and 30 lay people who give
advice from the patient's perspective.
Respondents were asked about their preferences and atti-
tudes toward advance directives by multiple answers.
Questionnaire items include those relating to how they
would like their treatment preferences to be made (ver-
bally or in writing), the appointment of a proxy for health
care decision-making, and the appointment of a legal
executor for dealing with property, and statement of pref-
erences regarding disposal of property and funeral
arrangements. Respondents were asked whether they
would like to express their preferences in advance toward
each item, or whether they have already expressed their
preferences.
Respondents were also asked about their preferences
toward treatment preferences that were translated from
American actual living will declarations17. The actual sen-
tences are: 'If my condition is determined to be terminal
and incurable, I do want life-sustaining procedures that
serve only to prolong the process of my dying.', 'If I am in
an irreversible or incurable persistent vegetative state, I do
want cardiac resuscitation.', 'If I am in an irreversible orBMC Medical Ethics 2006, 7:11 http://www.biomedcentral.com/1472-6939/7/11
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incurable persistent vegetative state, I do want artificial
nutrition and hydration.', 'I want my life to be prolonged
to the greatest extent possible.' The questionnaire asked
respondents to what extent they wanted to express their
preferences regarding treatment, how they would like to
discuss treatment preferences with their proxy, and to
what extent their proxy should respect the patient's treat-
ment preferences.
The questionnaire presented a hypothetical scenario ask-
ing respondents about their preferences toward certain
types of treatments in the event that they have limited
capacity to make decisions due to illness. We created three
types of scenarios with different diagnoses: dementia, irre-
versible coma, and temporary illness. One of the three sce-
narios was randomly assigned to each questionnaire so
that each respondent answered questions regarding one
situation only. The response rate toward each scenario
was quite similar with 60.7% (142/235) responses to the
dementia scenario, 59.5% (135/227) responses to the
irreversible coma scenario, and 62.1% (141/227)
responds to the temporary illness scenario. Questions
were identical in all scenarios. The questionnaire began
with the introduction: "If you acquired another illness
while having moderate/severe dementia, would you
choose to undergo the following medical treatments?"
Respondents were then asked about their preferences
toward a total of 8 active treatments (ATs) which have var-
ying degrees of burden/chance of success/length of sur-
vival. As former research indicates that advance directives
should take into account patients' attitudes toward the
burden of treatment, the possible outcomes, and their
likelihood25, we took these attributes into account when
developing the AT options for the questionnaire. Five
medical doctors and 30 lay people checked the validity,
adequacy and understandability of the expressions used.
No specific treatment was mentioned in the eight AT var-
iations, but they were defined by the combination of the
following characteristics: burden the AT imposes is low or
high, the chance of success is good or poor, and possible
outcome in terms of the length of survival is about 6
months when not treated as opposed to over 2 years when
treated in one version, less than 1 month when not treated
as opposed to about 6 months when treated in another
version. Examples of low-burden approaches were
described as therapies such as oral administration of med-
ication and intravenous antibiotics. Those of high-burden
approaches were described as surgery and medication
with possibly severe side effects.
Respondents were also asked about their preferences
toward 8 life-sustaining treatments (LSTs): 4 types of LST
with two different survival periods. The types of LST
included were cardio-pulmonary resuscitation, artificial
ventilation, dialysis, and artificial nutrition. Each treat-
ment prolongs the length of survival to over 2 years in one
version, and to about 6 months in another. The scenarios
stated that without these LSTs the patient would die
within a short time. The questions were intended to inves-
tigate whether respondents' preferences toward each type
of the LSTs would change if the length of survival is differ-
ent. As for the ATs, in which no treatment was specified,
respondents had to give their preferences in relation to
burden, chance of success and survival period, but for the
LSTs, the respondents had to give preferences regarding
the specific treatments and the length of survival.
The questionnaire also included the General Health Ques-
tionnaire 12 item Japanese version (GHQ-12), which
assesses predisposition to non-psychotic psychiatric
illness27,28. The Japanese version of GHQ-12 is stand-
ardized and widely used29,30. In the present sample, the
GHQ for Cronbach's α = 0.84.
We described the distributions of the study population,
their attitudes regarding advance directives and treatment
preferences. The Kruskal-Wallis test, χ2 test and Fisher
exact test were used to determine the differences in
respondents' characteristics among the three scenario
groups. Age was divided into one group consisting of
respondents aged 53 years (mean age in this study) and
another group aged 53 years and under. Scores regarding
GHQ were also analyzed according to 2 groups consisting
of the group of respondents who scored above 25 (the
mean total score of respondents in this study) and the
group of respondents who scored 25 and under. To exam-
ine the relationship between respondents' characteristics
and their preferences or attitudes toward treatments, we
used the total score of the LSTs and the ATs and compared
them with patients' characteristics (Range 0–8; for each
item, negative attitude = 0, positive attitude = 1). Mann-
Whitney's U-test was used to examine this relationship for
each scenario group. For each scenario group factor anal-
ysis using a promax rotation was used to identify the
underlying dimensions of the 16 treatment items: 8 varia-
tions of ATs and 4 types of LST with two different survival
periods. χ2 test was used to determine the differences in
treatment preferences among the three scenario groups.
All reported p values are two-sided. Statistical analyses
were conducted using SPSS Version 13.0J.
Results
The characteristics of respondents are shown in Table 1. A
total of 418 people responded with a mean age of 52.8
years ± 7.4 years. There were no significant differences in
the characteristics of respondents between the three sce-
nario groups. Respondents' attitudes toward advance
directives are shown in Table 2. Over 70% of respondents
would like to express treatment preferences orally andBMC Medical Ethics 2006, 7:11 http://www.biomedcentral.com/1472-6939/7/11
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would like to appoint a proxy for making care related deci-
sions.
Regarding preferences about medical treatments based on
the American format for Advance Directives, 72.7% of
respondents did not want life-sustaining procedures that
served only to prolong the process of dying if their condi-
tion is determined to be terminal and incurable, 81.6 %
did not want cardiac resuscitation if they are in an irrevers-
ible or incurable persistent vegetative state, 78.5% of them
did not want artificial nutrition and hydration if they are
in an irreversible or incurable persistent vegetative state,
and 6.9% of respondents wanted their life to be pro-
longed to the greatest extent possible.
Regarding the process for deciding treatment preferences,
73 (17.5%) respondents wanted to decide 'by oneself', 93
(22.2%) wanted to decide with their proxy (family or
friend), 46 (11.0%) wanted to decide with the doctor, and
200 (47.8%) wanted to decide with both their proxy and
the doctor. The degree of detail that respondents wished
preferences to be recorded in their advance plan also
showed strong variation with 56 (13.4%) respondents
stating that they 'definitely wanted' to describe their treat-
ment preferences in concrete terms, 104 (24.9%)
respondents 'preferred' to describe their treatment prefer-
ences in concrete terms, while 141 (33.7%) 'definitely
wanted' to indicate treatment preferences in broad terms,
and 109 (26.1%) 'preferred' to indicate treatment prefer-
ences in broad terms".
Regarding how often and when patients would like to dis-
cuss their treatment preferences with their proxy, 106
(25.4%) chose "regularly" and 214 (51.2%) chose "when
clinical conditions require", while 60 (14.4%) chose
"once", 20 (4.8%) chose "in absolute necessity" and 10
(2.4%) said "never". Concerning to what extent their
proxy should respect their treatment preferences, 21
(5.0%) said their preferences should be ''strictly observed"
and 243 (58.1%) said "as much as possible," while 137
(32.8%) respondents said "only as a reference", 11 (2.6%)
said "they would not care even if their preferences are not
observed".
Responses to preferences in the event of dementia found
that respondents who were married (p < 0.05) and who
lived with an infant child (p < 0.01) were more likely to
have positive attitudes toward ATs. Respondents' charac-
teristics did not affect responses to treatment preferences
in the case of the irreversible coma scenario. As for tempo-
rary illness, respondents aged over 53 (p < 0.01) and who
are female (p < 0.05), who lived with an adult child (p <
0.01), not living with an infant child (p < 0.01) were more
likely to have negative attitudes toward ATs. Respondents
who lived with an adult child (p < 0.05), who did not live
with a infant child (p < 0.05) also have negative attitudes
toward LSTs in the temporary illness scenario.
The distributions of ATs preferences based on three hypo-
thetical scenarios were shown in Table 3. Among the eight
ATs variations, the three scenario groups showed no sig-
nificant differences in responses to the following four
types of ATs: 1) a treatment that imposes high burden, has
poor chance of success and provides a 6-month life
expectancy when successfully treated and a 1 month life
expectancy when not treated, 2) a treatment that imposes
high burden, has poor chance of success and provides
over a two-year life expectancy when successfully treated
and a 6-month life expectancy when not treated, 3) a treat-
ment that imposes high burden, good chance of success
and provides a 6-month life expectancy when successfully
Table 1: Characteristics of respondents (N = 418)
Mean SD
Age (yrs) 52.8 ± 7.4
GHQ (total score) 24.7 ± 5.0
N%
Sex (female) 241 (57.7)
College Graduates 114 (27.3)
Living Alone 51 (12.2)
Married 319 (76.3)
Living with Adult Child 153 (36.6)
Living with Infant Child 127 (30.4)
No Religion 324 (77.5)
Table 2: Patient's attitudes toward advance directives (N = 418) MA
Items for determination would like to express his/her preferences have already expressed his/her preferences
N%N%
Treatment preferences (orally) 308 73.7 85 20.3
Treatment preferences (in writing) 251 60.0 11 2.6
Appointing proxy of care decision 296 70.8 17 4.1
Appointing legal administrator of property 253 60.5 12 2.9
Disposal of one's property 262 62.7 10 2.4
Funeral arrangements 255 61.0 38 9.1BMC Medical Ethics 2006, 7:11 http://www.biomedcentral.com/1472-6939/7/11
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treated and a 1-month life expectancy when not treated,
4) a treatment that imposes low burden, has poor chance
of success and provides a 6-month life expectancy when
successfully treated and a 1-month life expectancy when
not treated. The distributions of LSTs preferences based on
three hypothetical scenarios were shown in Table 4.
Among the eight LSTs variations, the three scenario
groups showed significant differences in responses to
preferences for the different types of treatments.
Factor analysis was conducted on each scenario group (see
Table 5, 6, 7). In the dementia scenario (Table 5) and tem-
porary illness scenario (Table 7), Factor 1 items were com-
posed of LSTs and Factor 2 items were composed of 4
types of ATs all of which imposed high burden. In the irre-
versible coma scenario (Table 6), Factor 1 items were
composed of 4 types of LSTs all of which provide over 2
years life expectancy and Factor 2 items were composed of
4 types of LSTs all of which provide about 6 months life
expectancy. Eight type of LSTs accounted for the nearly
half of the total variance in the analyses conducted on
each scenario (Dementia 45.6%, Irreversible Coma
57.4%, Temporary illness 41.6%).
Discussion
This study revealed that many middle-aged and senior
people in Tokyo indicate an interest in undertaking
advance directives. Nearly three-quarters (73.7%) of
respondents in this study said that they would like to ver-
bally express their treatment preferences in advance. This
result is reflected in other research conducted in Japan
which found that 80.5% of a general public sample
strongly/moderately agreed with advance directives [12].
However the fact that only 20.3% of the people in our
study had already undertaken advance directives indicates
that despite a interest, barriers exist to carrying this out
(Table 2). While there is strong recognition of the benefits
of undertaking advance directives with over 60% of
respondents agreed that it is preferable to express their
wishes regarding the appointment of a proxy for care deci-
sions, appointment of a legal administrator of property,
stating preferences regarding one's property and funeral
arrangements, less than 10% of them had already done so
(Table 2). The existence of a number of barriers to under-
taking advance directives has been identified in the litera-
ture. Research indicates that Japanese people have
difficulty in actually expressing their preferences regarding
advance directives even in the case that they are willing do
so[32] Furthermore, dementia has been identified as con-
tributing to difficulties in encouraging advance directives
policies. Our former study showed that of the nursing
homes in Japan that confirm their residents' preferences
regarding advance directives, for the most part, this is only
undertaken some time after patients have been admitted











6 mo. + 2 yr 6 mo. + 2 yr 6 mo. + 2 yr 6 mo. + 2 yr
% (distribution of patients who want treatment)
Dementia 23.2 % (32) 29.0 % (40) 27.5 % (38) 36.2 % (50) 25.4 % (35) 33.3 % (46) 26.8 % (37) 33.3 % (46)
Irreversible 
Coma
20.9 % (28) 24.6 % (33) 23.9 % (32) 29.9 % (40) 23.1 % (31) 27.6 % (37) 29.9 % (40) 32.8 % (44)
Temporary 
Illness
44.4 % (60) 59.3 % (80) 52.2 % (71) 64.7 % (88) 48.9 % (66) 67.4 % (91) 46.3 % (63) 61.0 % (83)
p < .001 p < .001 p < .001 p < .001 p < .001 p < .001 p < .01 p < .001
χ2 = 21.9 χ2 = 41.0 χ2 = 28.5 χ2 = 38.0 χ2 = 25.1 χ2 = 51.1 χ2 = 13.3 χ2 = 29.0
Table 3: Distribution of patients who want treatment (N = 418)
Burden high high high high Low low low low
Chance of success in 
the treatment
poor poor good good Poor poor good good
Life expectancy 
(success/failure)
6 mo./1 mo. + 2 yrs/6 mo. 6 mo./1 mo. +2 yr/6 mo. 6 mo./1 mo. +2 yr/6 mo. 6 mo./1 mo. + 2 yr/6 mo.
% (distribution of patients who want treatment)
Dementia 4.4 % (6) 4.4 % (6) 17.6 % (24) 29.9 % (41) 27.7 % (38) 31.4 % (43) 65.7 % (90) 76.1 % (105)
Irreversible Coma 6.1 % (8) 5.3 % (7) 18.0 % (24) 16.5 % (22) 24.2 % (32) 26.3 % (35) 50.4 % (67) 64.4 % (87)
Temporary Illness 3.0 % (4) 8.3 % (11) 18.9 % (25) 38.3 % (51) 29.3 % (39) 45.1 % (60) 74.5 % (102) 94.9 % (131)
N.S. N.S. N.S. p < .001 N.S. P < .01 p < .001 p < .001
χ2 = 1.44 χ2 = 2.02 χ2 = 0.79 χ2 = 15.9 χ2 = 0.91 χ2 = 11.2 χ2 = 17.3 χ2 = 38.5BMC Medical Ethics 2006, 7:11 http://www.biomedcentral.com/1472-6939/7/11
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[31]. However, this may be inappropriately late given that
more than a majority of residents have difficulties in daily
life due to dementia. While it is clear that it is highly desir-
able for patients to undertake advance directives before
dementia has reached advanced stages, in many cases,
treatment preference made might not be respected
because of patients' difficulties in expressing preferences
and nursing home attitudes that do not validate advance
directives in a positive way. In order to ensure that the
treatment preferences of the general public in Japan are
recognized and met, some support for individuals as well
as nursing homes and medical professionals is necessary.
About 60% of respondents in this study preferred to indi-
cate treatment preferences in broad rather than concrete
terms. Over 80% would like to decide treatment prefer-
ences in consultation with others (22.2% with their proxy,
11.0% with the doctor, and 47.8% with both their proxy
and the doctor) and over 75% of respondents would like
the opportunity to discuss their treatment preferences
with their proxy more than once (51.2% when clinical
conditions require, 25.4% regularly). Respondents
responses reflected a range of preferences regarding how
advance directives are undertaken, thus it is important to
recognize that any processes put into place should allow
flexibility in order to best respect patients' wishes and
Table 6: Factor analysis toward 16 treatment variations in irreversible coma scenario. (N = 135)
Items Factor 1 Factor 2 Factor 3 Factor 4
Variance 46.0% 11.4% 8.4% 6.7%
Low burden, Good chance, 2 years .400 .468 .780 .182
High burden, Good chance, 2 years .262 .388 .452 .783
Low burden, Poor chance, 2 years .326 .148 .755 .495
High burden, Poor chance, 2 years .505 .126 .266 .780
Low burden, Good chance, 6 months .258 .513 .862 .282
High burden, Good chance, 6 months .212 .630 .456 .698
Low burden, Poor chance, 6 months .361 .185 .758 .535
High burden, Poor chance, 6 months .381 .408 .313 .806
CPR, 2 years .905 .481 .321 .373
Artificial Ventilator, 2 years .906 .497 .374 .421
Dialysis, 2 years .732 .534 .524 .290
Artificial Nutrition, 2 years .754 .617 .438 .295
CPR, 6 months .691 .784 .259 .412
Artificial Ventilator, 6 months .627 .778 .310 .411
Dialysis, 6 months .470 .879 .387 .267
Artificial Nutrition, 6 months .546 .827 .400 .339
* All loadings greater than 0.50 are in bold type
Table 5: Factor analysis toward 16 treatment variations in dementia scenario. (N = 142)
Items Factor 1 Factor 2 Factor 3 Factor 4
Variance 45.6% 14.8% 9.7% 6.9%
Low burden, Good chance, 2 years .372 .199 .906 .213
High burden, Good chance, 2 years .518 .662 .596
Low burden, Poor chance, 2 years .201 .319 .330 .903
High burden, Poor chance, 2 years .207 .869 .130 .331
Low burden, Good chance, 6 months .458 .249 .894 .303
High burden, Good chance, 6 months .560 .778 .471
Low burden, Poor chance, 6 months .170 .322 .277 .926
High burden, Poor chance, 6 months .207 .869 .130 .331
CPR, 2 years .815 .262 .446 .113
Artificial Ventilator, 2 years .866 .319 .468 .203
Dialysis, 2 years .822 .303 .502 .115
Artificial Nutrition, 2 years .826 .340 .424
CPR, 6 months .835 .322 .409
Artificial Ventilator, 6 months .884 .347 .386 .116
Dialysis, 6 months .886 .356 .419
Artificial Nutrition, 6 months .872 .361 .403
* All loadings greater than 0.50 are in bold typeBMC Medical Ethics 2006, 7:11 http://www.biomedcentral.com/1472-6939/7/11
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autonomy. In the case of shared treatment decision-mak-
ing, further investigation is required to examine what
processes would be appropriate in order to respond to
patients and their surrogate decision makers' desires.
Even in the case of advance directives that does not specify
detail, patient wishes do need to distinguish between pref-
erences that arise in the cases of different kinds of compli-
cations that occur toward the end of life including
irreversible coma, dementia and temporary illness.
Respondents' preferences varied amongst the scenarios for
the four active treatments and all the life-sustaining treat-
ments. Moreover results of factor analysis for three of the
scenarios are slightly different with patient preferences
ranged from high rates of desire to receive treatments in
the event of temporary illness to high rates of treatment
rejection in the case of irreversible coma. Similar results
have also been reported elsewhere [33,34]. In research
conducted in Japan on advance directives making in the
event of terminal illness, Asai [19] suggested that Japanese
terminally patients, despite having competency to do so,
might not actually be able to make their advance direc-
tives concrete enough to guide physician's decisions.
Given these findings, it might be need to consider distin-
guishing diagnoses for which a Japanese advance directive
format applies or does not apply.
This research found that the burden of treatment and the
likelihood of outcome all influenced treatment prefer-
ences, consistent with results found in another study [25].
The results of the factor analysis on preference suggest that
patient' preferences toward LSTs and burden of treatments
should always be confirmed when asking about treatment
preferences in end-of-life situation. However LSTs
accounted for the nearly half of the total variance in the
analyses conducted on each scenario. As four types of high
burden ATs were Factor 2 in both the dementia and tem-
porary illness scenarios and 4 types of low burden ATs
were Factor 3 in the irreversible coma scenario, the second
biggest factor affecting preferences might be the perceived
level of burden of ATs. If patients would like to indicate
treatment preferences in a broad sense rather than con-
crete terms, it might be possible to do so by putting all
LSTs and high burden treatments in one category, without
specifying treatment. Further studies will be required to
confirm whether this simplification is appropriate or not.
This research's results suggest that type of diagnosis given
to the general public members in this sample and their
characteristics have little effect when they have only severe
treatment outcome. Three of the scenario groups showed
no significant differences in preferences to four types of
active treatments, of which at least two had negative
attributes of burden, chances of success and life expect-
ancy. On the other hand respondents' characteristics did
not affect treatment preferences in the irreversible coma
scenario, while many characteristics significantly affected
preferences in the other two scenarios. Many respondents
refused high burden, poor likelihood treatments even in
temporary illness scenario which is relatively healthy
state. As temporary illness is defined "decisional incapac-
ity state cause by such as mental disorders, and people
would soon recover capacity", respondents might con-
sider their choice only for incapacity period.
As this study is a cross sectional survey in Japan, these
results may not be simply applicable to other country.
Though the desire for group decision making might be
Table 7: Factor analysis toward 16 treatment variations in temporary illness scenario. (N = 141)
Items Factor 1 Factor 2 Factor 3 Factor 4
Variance 41.6% 11.8% 8.1% 7.0%
Low burden, Good chance, 2 years .261 .120 .735
High burden, Good chance, 2 years .500 .744 .381
Low burden, Poor chance, 2 years .297 .333 .832 .186
High burden, Poor chance, 2 years .132 .806 .287
Low burden, Good chance, 6 months .366 .113 .303 .808
High burden, Good chance, 6 months .397 .681 .485
Low burden, Poor chance, 6 months .310 .230 .885 .231
High burden, Poor chance, 6 months .174 .683 .362
CPR, 2 years .840 .298 .240 .382
Artificial Ventilator, 2 years .830 .256 .218 .334
Dialysis, 2 years .802 .274 .177 .233
Artificial Nutrition, 2 years .781 .382 .273
CPR, 6 months .867 .253 .297 .489
Artificial Ventilator, 6 months .859 .227 .310 .459
Dialysis, 6 months .824 .267 .224 .435
Artificial Nutrition, 6 months .842 .347 .188 .402
* All loadings greater than 0.50 are in bold typeBMC Medical Ethics 2006, 7:11 http://www.biomedcentral.com/1472-6939/7/11
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different in Japan in comparison to Western countries, a
former study suggests that Japanese patients' preference
for disclosure, willingness to forgo care, and views regard-
ing advance directives are shifting toward those found in
the West [35]. As respondents' preferences regarding life-
sustaining treatment in this study (23%–36% wanting
LSTs in the case of dementia;21%–33% wanting LSTs in
the cse of Coma) are similar to those found in the United
States (23% to 42% wanting LSTs in the case of dementia;
about 14–29) wanting LSTs in the case of Irreversible
coma 17, 23, our previous study shows a similar tendency
between the two countries regarding patients' preferences
and cancer disclosure[36]. Despite differences between
Japanese and western and US medical institutional poli-
cies and doctors' attitudes regarding advance directives
[37], it is suggested that there is little difference in
patients' side preferences regarding treatment preferences.
We would like to make a couple of comments on the rep-
resentative-ness of this survey's sample. The response rate
for this study was generally good for a general population
survey, though slight lower that of a similar Japanese
study which found that 80.5% of respondent strongly/
moderately agreed with advance directives12. We there-
fore believe that the response rate did not significantly
affect the overall results obtained in our study. However
this study's sample was limited to residents who reside in
Tokyo aged between 40 and 65. As the Tokyo is the most
condensed and diverse metropolitan area in Japan, further
research is needed in order to collect and comparing our
results with data collected in rural areas and smaller towns
and cities. It is also required to add younger (under the age
of 40) and older people (over the age of 65) in further
research to consider generalization of these findings.
In order to respect Japanese patients' preferences, it might
be important to implement flexible processes and prac-
tices that are able to accommodate patients' preferences as
well as nursing homes and medical professionals needs
regarding advance directives and surrogate decision mak-
ing. Specific to the Japanese context, the results of this sur-
vey indicate that advance directives might need to
differentiate processes according to diagnoses including
LSTs and high burden ATs treatment items.
Conclusion
This study revealed that many Japanese people indicate an
interest in undertaking advance directives.  This study
found that there is a range of preferences regarding how
advance directives are undertaken, thus it is important to
recognize that any processes put into place should allow
flexibility in order to best respect patients’ wishes and
autonomy.
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